文献速递临床试验与 GCP真实世界研究与卫生经济

预防产后复吸的经济激励(FIPPS):三臂随机对照试验研究方案

Financial Incentives for Preventing Postpartum return to Smoking (FIPPS): study protocol for a three-arm randomised controlled trial.
PubMed 文献 · Trials · 2021-08-02

该英国多中心三臂优效性平行组个体随机对照试验,将产后戒烟维持者按1:1:1分配至产后3个月最多120英镑激励组、产后12个月最多300英镑激励组或无激励常规照护组。主要结局为从孕期最后一次戒烟尝试至产后12个月的自报无复吸戒烟,经呼出气一氧化碳和/或唾液可替宁或新烟草碱生化验证。

要点

  • 比较产后3个月与12个月经济激励方案预防产后复吸的效果与成本效果。
  • 主要结局为产后12个月生化验证的无复吸戒烟,按意向性分析比较组间戒烟比例。
  • 纳入孕34周至产后2周、戒烟至少4周且呼出气一氧化碳<4 ppm的≥16岁女性。

核心结论

  • 该试验将检验产后提供经济激励对帮助女性避免产后12个月内复吸是否有效且具成本效果。

研究设计与样本

  • 英国多中心、三臂、优效性、平行组、个体随机对照试验,按1:1:1分配。
  • 两组激励干预分别为产后最多3个月提供最多120英镑(参与者60英镑+重要他人支持60英镑)和产后最多12个月提供最多300英镑(参与者240英镑+重要他人支持60英镑),并与无激励/常规照护组比较。
  • 纳入标准为孕34周至产后2周、戒烟至少4周、呼出气一氧化碳<4 ppm、年龄至少16岁、打算产后继续戒烟且能说读英语的女性。

关键数值与推荐

  • 主要结局为从孕期最后一次戒烟尝试至产后12个月的自报无复吸戒烟,经呼出气一氧化碳和/或唾液可替宁或新烟草碱生化验证。
  • 采用意向性分析和回归模型比较两个干预组之间以及各干预组与对照组之间戒烟女性比例。
  • 将开展经济学评价评估提供激励的成本效果,并进行定性过程评价考察试验保留、效果和实施的障碍与促进因素。

临床怎么用

  • 若证实有效且具成本效果,产后经济激励或可成为预防产后复吸的干预选项。

局限性

  • 该文为研究方案,尚未报告试验结果。
  • 试验注册为回顾性注册(2019年6月5日)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Financial incentives are an effective way of helping women to stop smoking during pregnancy. Unfortunately, most women who stop smoking at this time return to smoking within 12 months of the infant's birth. There is no evidence for interventions that are effective at preventing postpartum smoking relapse. Financial incentives provided after the birth may help women to sustain cessation. This randomised controlled trial will assess the effectiveness and cost-effectiveness of financial incentives to help women who are abstinent from smoking at end-of-pregnancy to avoid return to smoking up to 12 months postpartum. METHODS: This is a UK-based, multi-centre, three-arm, superiority, parallel group, individually randomised controlled trial, with 1:1:1 allocation. It will compare the effectiveness of two financial incentive interventions with each other (one intervention for up to 3 months postpartum offering up to £120 of incentives (£60 for the participant and £60 for a significant other support); the other for up to 12 months postpartum with up to £300 of incentives (£240 for the participant and £60 for a significant other support) and with a no incentives/usual care control group. Eligible women will be between 34 weeks gestation and 2 weeks postpartum, abstinent from smoking for at least 4 weeks, have an expired carbon monoxide (CO) reading < 4 parts per million (ppm), aged at least 16 years, intend remaining abstinent from smoking after the birth and able to speak and read English. The primary outcome is self-reported, lapse-free, smoking abstinence from the last quit attempt in pregnancy until 12 months postpartum, biochemically validated by expired CO and/or salivary cotinine or anabasine. Outcomes will be analysed by intention-to-treat and regression models used to compare the proportion of abstinent women between the two intervention groups and between each intervention group and the control group. An economic evaluation will assess the cost-effectiveness of offering incentives and a qualitative process evaluation will examine barriers and facilitators to trial retention, effectiveness and implementation. DISCUSSION: This pragmatic randomised controlled trial will test whether offering financial incentives is effective and cost-effective for helping women to avoid smoking relapse during the 12 months after the birth of their baby. TRIAL REGISTRATION: International Standard Randomised Controlled Trial Number 55218215 . Registered retrospectively on 5th June 2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Ussher M, Best C, Lewis S, et al. Financial Incentives for Preventing Postpartum return to Smoking (FIPPS): study protocol for a three-arm randomised controlled trial. Trials. 2021. PMID: 34340694. doi:10.1186/s13063-021-05480-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。